ceric oxide has been researched along with Fibrosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Darroudi, M; Kazemi Oskuee, R; Khoshdel-Sarkarizi, H; Nedaeinia, R; Nourmohammadi, E | 1 |
| Darroudi, M; Hasanzadeh, L; Kazemi Oskuee, R; Khoshdel-Sarkarizi, H; Nedaeinia, R; Nourmohammadi, E; Sadeghnia, HR | 1 |
| Ahamed, M; Akhtar, MJ; Alhadlaq, HA; Alrokayan, SA; Khan, MAM | 1 |
3 other study(ies) available for ceric oxide and Fibrosarcoma
| Article | Year |
|---|---|
Cerium oxide nanoparticles: A promising tool for the treatment of fibrosarcoma in-vivo.
Topics: Animals; Cell Line, Tumor; Cerium; Female; Fibrosarcoma; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms, Experimental | 2020 |
Evaluation of anticancer effects of cerium oxide nanoparticles on mouse fibrosarcoma cell line.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Survival; Cerium; Fibrosarcoma; L Cells; Mice; Nanoparticles; Oxidative Stress; Protective Agents; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species | 2019 |
Glutathione replenishing potential of CeO₂ nanoparticles in human breast and fibrosarcoma cells.
Topics: Antioxidants; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cerium; Female; Fibrosarcoma; Glutathione; Humans; Nanoparticles; Reactive Oxygen Species | 2015 |